RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Return
12.81%
This Quarter Return
+10.59%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$998M
AUM Growth
+$20.9M
(+2.1%)
Cap. Flow
-$70.6M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
91
New
2
Increased
24
Reduced
43
Closed
3
Top Buys
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
$20M |
| 2 |
Cigna
CI
|
$9.22M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$7.15M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$6.77M |
| 5 |
Biogen
BIIB
|
$6.01M |
Top Sells
Sector Composition
| 1 | Healthcare | 91.36% |
| 2 | Financials | 1.12% |
| 3 | Technology | 0.14% |
| 4 | Energy | 0.14% |
| 5 | Communication Services | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Edwards Lifesciences
EW
$47.4B
| $16.8M | 1.68% |
289,755
+84,663
| +41% | +$4.91M |
|
|
CELG
27
DELISTED
Celgene Corp
CELG
| $16.2M | 1.62% |
180,698
-30,000
| -14% | -$2.68M |
|
28
Esperion Therapeutics
ESPR
$498M
| $15.7M | 1.57% |
353,961
-52,400
| -13% | -$2.32M |
|
29
FibroGen
FGEN
$46.9M
| $15.3M | 1.53% |
10,048
+466
| +5% | +$708K |
|
30
Alnylam Pharmaceuticals
ALNY
$59.5B
| $15M | 1.51% |
171,950
+57,983
| +51% | +$5.07M |
|
31
Gilead Sciences
GILD
$140B
| $14.6M | 1.47% |
189,647
-72,380
| -28% | -$5.59M |
|
32
Iovance Biotherapeutics
IOVA
$778M
| $14.5M | 1.45% |
1,290,495
+443,019
| +52% | +$4.98M |
|
|
ITCI
33
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $14.2M | 1.42% |
654,982
-41,975
| -6% | -$911K |
|
|
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.9M | 1.39% |
180,000
-50,000
| -22% | -$3.86M |
|
|
AGN
35
DELISTED
Allergan plc
AGN
| $13.3M | 1.34% |
70,045
-55,000
| -44% | -$10.5M |
|
36
Boston Scientific
BSX
$160B
| $13M | 1.3% |
337,968
-10,000
| -3% | -$385K |
|
37
Alkermes
ALKS
$4.78B
| $12.8M | 1.28% |
301,610
+11,610
| +4% | +$493K |
|
38
AbbVie
ABBV
$375B
| $12.3M | 1.23% |
130,000
+60,000
| +86% | +$5.67M |
|
|
MYOK
39
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $12.3M | 1.23% |
188,272
-10,000
| -5% | -$652K |
|
40
LivaNova
LIVN
$3.15B
| $11.8M | 1.18% |
95,000
+10,000
| +12% | +$1.24M |
|
|
ARRY
41
DELISTED
Array Biopharma Inc
ARRY
| $11.7M | 1.17% |
768,370
+45,000
| +6% | +$684K |
|
42
Agios Pharmaceuticals
AGIO
$2.09B
| $11.2M | 1.12% |
145,428
-15,000
| -9% | -$1.16M |
|
|
AERI
43
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $11.1M | 1.11% |
180,000
+110,000
| +157% | +$6.77M |
|
|
44
Biogen
BIIB
$20.3B
| $10.6M | 1.06% |
30,000
+17,000
| +131% | +$6.01M |
|
|
WBA
45
DELISTED
Walgreens Boots Alliance
WBA
| $10.6M | 1.06% |
145,000
-185,000
| -56% | -$13.5M |
|
|
AET
46
DELISTED
Aetna Inc
AET
| $10.1M | 1.02% |
50,000
-20,000
| -29% | -$4.06M |
|
47
Neurocrine Biosciences
NBIX
$13.7B
| $10M | 1.01% |
81,677
-28,700
| -26% | -$3.53M |
|
|
FLXN
48
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $9.97M | 1% |
532,812
+181,026
| +51% | +$3.39M |
|
49
Cencora
COR
$56.9B
| $9.36M | 0.94% |
101,520
-22,741
| -18% | -$2.1M |
|
|
IMMU
50
DELISTED
Immunomedics Inc
IMMU
| $8.86M | 0.89% |
425,330
-30,000
| -7% | -$625K |
|